# Anthocyanin Cognition Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/anthocyanin-cognition-randomized-trial-evidence-review
Category: evidence-review
Summary: Anthocyanin Cognition Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-08-05
Reviewed by: Migaku Evidence Review
# Anthocyanin Cognition Randomized Trial: What the Evidence Says

## Quick Answer

Anthocyanin Cognition Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Anthocyanin-Rich Extracts from Bilberries and Blackcurrants in Human Health: A Narrative Review of Their Anti-Inflammatory and Antioxidant Effects | preclinical study | 4 | 2026-03-09 | 10.3390/jcm15052083 |

## What The Sources Report

- Aging is a complex process that involves physiological, molecular, and cellular changes over time, and has been associated with an increase in susceptibility to various pathological conditions, including neurodegenerative and cardiovascular diseases (CVD), dyslipidemia, or type 2 diabetes (T2D). [Escobar-Cervantes Carlos (2026); evidence level 4]
- Additionally, mitochondria, the main sources of ROS, become dysfunctional with age, contributing to increased oxidative stress and cellular deterioration. [Escobar-Cervantes Carlos (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For anthocyanin cognition randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Escobar-Cervantes Carlos (2026). Anthocyanin-Rich Extracts from Bilberries and Blackcurrants in Human Health: A Narrative Review of Their Anti-Inflammatory and Antioxidant Effects. DOI: 10.3390/jcm15052083. PMCID: PMC12985782. PMID: 41827500. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12985782/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.